SALT Holding Corp.

Position in GSK — GSK plc

CIK 1996109 WILMINGTON, DE

Position in GSK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$12,342,760

+$8,830,631 QoQ

Shares Held

235,459

+159.7% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

6.54%

of 13F equity value

Holder Rank

#97

of 1,032 holders

Holding Since

Dec 2024

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SALT Holding Corp. holds $52,779,679 across 4 Drug Manufacturers - General names. GSK ranks #2 (23.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	93,250	$17,682,065
2	GSK	GSK plc This page	235,459	$12,342,760
3	NVO	Novo Nordisk A S	256,134	$12,279,063
4	NVS	Novartis AG	66,844	$10,475,791

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,342,760	235,459	+159.7%	Shares	Other	2026-08-14
2025-03-31	$3,512,129	90,659	+47.1%	Shares	Other	2025-05-14
2024-12-31	$2,083,717	61,612	—	Shares	Other	2025-02-14
No filing history on record for this holder in this stock.